Ca2+-dependent regulation of calcitonin gene expression by the transcriptional repressor DREAM

Endocrinology

Volumn 147, Issue 10, 2006, Pages 4608-4617

  Matsuda, Miho ^a   Yamamoto, Tada Aki ^a   Hirata, Masato ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM IONOPHORE; CALSENILIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; CALCIUM; CSEN PROTEIN, HUMAN; DIAGNOSTIC AGENT; GLUTATHIONE TRANSFERASE; IONOPHORE; KV CHANNEL INTERACTING PROTEIN; LUCIFERASE; NUCLEAR PROTEIN; REPRESSOR PROTEIN;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME ASSAY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE RELEASE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; THYROID CARCINOMA; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CALCITONIN; CALCIUM; CELL LINE, TUMOR; CYCLIC AMP; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOPRECIPITATION; IONOPHORES; KV CHANNEL-INTERACTING PROTEINS; LUCIFERASES; NUCLEAR PROTEINS; PLASMIDS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TRANSFECTION;

EID: 33748746769     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0254     Document Type: Article

References (53)

1. Copp DH, Cameron EC, Cheney BA, Davidson AGF, Henze KG 1962 Evidence for calcitonin - a new hormone from the parathyroid that lowers blood calcium. Endocrinology 70:638-649
2. Hoff AO, Lehnen PC, Thomas PM, Priemel M, Rueger JM, Nasonkin I, Bradley A, Hughes MR, Ordonez N, Cote GJ, Amling M, Gagel RF 2002 Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest 110:1849-1857
3. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM 1982 Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244
4. Jacobs JW, Goodman RH, Chin WW, Dee PC, Habener JF, Bell NH, Potts Jr JT 1981 Calcitonin messenger RNA encodes multiple polypeptides in a single precursor. Science 213:457-459
5. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM 1983 Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129-135
6. Rosenfeld MG, Amara SG, Evans RM 1984 Alternative RNA processing: determining neuronal phenotype. Science 225:1315-1320
7. Coleman TP, Tran Q, Roesser JR 2003 Binding of a candidate splice regulator to a calcitonin-specific splice enhancer regulates calcitonin/CGRP pre-mRNA splicing. Biochim Biophys Acta 1625:153-164
8. Lou H, Ragel RF 1998 Alternative RNA splicing-its role in regulating expression of calcitonin/calcitonin gene-related peptide. J Endocrinol 156:401-405
9. Lou H, Neugebauer KM, Gagel RF, Berget SM 1998 Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol 18:4977-4985
10. Messina M, Yu MDT, Both GW, Molloy PL, Robinson BG 2003 Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells. J Clin Endocrinol Metab 88:1310-1318
11. Tran Q, Roesser JR 2003 SRp55 is a regulator of calcitonin/CGRP alternative RNA splicing. Biochemistry 42:951-957
12. Thiagalingam A, deBustros A, Baylin SB, Borges M, Jasti R, Compton D, Diamond L, Mabry M, Ball DW, Baylin SB, Nelkin BD 1996 RREB-1, a novel zinc finger protein, is involved in the differentiation response to ras in human medullary thyroid carcinomas. Mol Cell Biol 16:5335-5345
13. Viney TJ, Schmidt TW, Gierasch W, Sattar AW, Yaggie RE, Kuburas A, Quinn JP, Coulson JM, Russo AF 2004 Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J Biol Chem 279:49948-49955
14. 2+-regulated transcriptional repressor. Nature 398:80-84
15. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S 1998 Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150
16. Fujii M, Ohtsubo M, Ogawa T, Kamata H, Hirata H, Yagisawa H 1999 Real-time visualization of PH domain-dependent translocation of phospholipase C-δ1 in renal epithelial cells (MDCK): response to hypo-osmotic stress. Biochem Biophys Res Commun 254:284-291
17. Matsuda M, Sakamoto N, Fukumaki Y 1992 δ-Thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter. Blood 80:1347-1351
18. 45Ca autoradiography on nitrocellulose membrane after sodium dodecyl sulfate gel electrophoresis. J Biochem 95:511-519
19. C-Hicok J, Lin L, Spiro C, Laybourn PJ, Tschumper R, Rapacz B, McMurray CT 1994 Induction of the rat prodynorphin gene through Gs-coupled receptors may involve phosphorylation-dependent derepression and activation. Mol Cell Biol 14:2837-2848
20. Ledo F, Carrion AM, Link WA, Mellstrom B, Naranjo JR 2000 DREAM-αCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol 20:9120-9126
21. Rivas M, Mellstrom B, Naranjo JR, Santisteban P 2004 Transcriptional repressor DREAM interacts with thyroid transcription factor-1 and regulates thyroglobulin. J Biol Chem 279:33114-33122
22. Tverberg LA, Russo AF 1993 Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helix-loop-helix and octamer-binding transcription factors. J Biol Chem 268:15965-15973
23. deBustros A, Ball DW, Peters R, Compton D, Nelkin BD 1992 Regulation of human calcitonin gene transcription by cyclic AMP. Biochem Biophys Res Commun 189:1157-1164
24. deBustros A, Baylin SB, Levine MA, Nelkin BD 1986 Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J Biol Chem 261:8036-8041
25. Monla YT, Peleg S, Gagel RF 1995 Cell type-specific regulation of transcription by cyclic adenosine 3,′5′-monophosphate-responsive elements within the calcitonin promoter. Mol Endocrinol 9:784-793
26. Costigan M, Woolf CJ 2002 No DREAM, no pain: closing the spinal gate. Cell 108:297-300
27. 2+-dependent block of CREB-CBP transcription by repressor DREAM. EMBO J 21:4583-4592
28. Briemer LH, MacIntyre I, Zaidi M 1988 Peptides from the calcitonin genes. Molecular genetics, structure and function. Biochem J 255:377-390
29. Zaidi M, Inzerillo AM, Moonga BS, Bevis PJR, Huang CLH 2002 Forty years of calcitonin - where are we now? Bone 30:655-663
30. Chambers TJ, Magnus CJ 1982 Calcitonin alters behaviour of isolated osteoclasts. J Pathol 136:97-106
31. Zaidi M, Shanker VS, Huang CLH, Pazianas M 1994 Molecular mechanisms of calcitonin action. Endocr J 2:459-467
32. Yumita S, Nicholson GG, Rowe DJ, Kent GN, Martin TJ 1991 Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts. J Bone Miner Res 6:591-597
33. Moonga BS, Moss DW, Patchell A, Zaidi M 1990 Intracellular regulation of enzyme secretion from rat osteoclatss and evidence for a functional role in bone resorption. J Physiol 429:29-45
34. See ACH, Soo KC, 1997 Hypocalcaemia following thyroidectomy for thyrotoxicosis. Br J Surg 84:95-97
35. Zaidi M, Shanker VS, Adebamjo OA, Lai FA, Paziana M, Sunavala G, Spielman AI, Rifken BR 1996 Regulation of extracellular calcium sensing in rat osteoclasts by femtomolar calcitonin concentrations. Am J Physiol Renal Physiol 271:F637-F644
36. Okubo Y, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Iizuka T 2000 Effect of e-calcitonin on oeteoinduction by recombinant human bone morphogenetic perotein-2. Biochem Biophys Res Commun 269:317-321
37. Farley J, Dimai HP, Stilt-Coffing B, Farley P, Pham T, Mohan S 2000 Calcitonin increases the concentration of insulinplike growth factor in serum-free cultures of human osteoblast-like cells. Calcif Tissue Int 67:247-254
38. Plotkin LI, Weinstein RS, Parfitt AM, Robertson PK, Manolagas SC, Bellido T 2000 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374
39. Yoshida N, Yoshida T, Nakamura A, Monkawa T, Hayashi M, Saruta T 1999 Calcitonin induces 25-hydroxyvitamin D3 1α hydroxylase mRNA expression via protein kinase C pathway in LLCPK1 cells. J Am Soc Nephrol 10:2474-2479
40. El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA 2005 A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int 67:2039-2045
41. Chen G, Jayawickreme C, Way J, Armour S, Queen K, Watson C, Ignar D, Chen W, Kenakin T 1999 Constitutive receptor systems for drug discovery. J Pharmacol Toxicol Mech 42:199-206
42. Carrion AM, Mellstrom B, Naranjo JR 1998 Protein kinase A-dependent depression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol 18:6921-6929
43. Sanz C, Mellstrom B, Link WA, Naranjo JR, Fernandez-Luna JL 2001 Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic cells. EMBO J 20:2286-2292
44. 2+-dependent transcriptional repression and derepression: DREAM, a diresct effector. Semin Cell Dev Boil 12:59-63
45. Scsucova S, Palacios D, Savignatic M, Mellstrom B, Naranjo JR, Aranda A 2005 The repressor DREAM acts as a transcriptional activator on vitamin D and retinoic acid response elements. Nucleic Acids Res 33:2269-2279
46. Ledo F, Link WA, Carrion AM, Echeverria V, Mellstrom B, Naranjo JR 2000 The DREAM-DRE interaction: key nucleotides and dominant negative mutants. Biochim Biophys Acta 1498:162-168
47. Freichel M, Lorenz AZ, Holloschi A, Hafner M, Flockerzi V, Raue F 1996 Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology 137:3842-3848
48. Bouschet T, Henley JM 2005 Calcium as an extracellular signalling molecule: perspectives on the calcium sensing receptor in the brain. C R Biol 328:691-700
49. Ikura M, Osawa M, Ames JB 2002 The role of calcium-binding proteins in the control of transcription: structure to function. Bioessays 24:625-636
50. Nichols M, Weith F, Schmid W, DeVack C, Kowenz-Leutz E, Luckow B, Boshart M, Schultz G 1992 Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP-induced gene transcription. EMBO J 11:3337-3346
51. Parker D, Ferreri K, Nakajima T, LaMorte VJ, Evans R, Koerber SC, Hoeger C, Montminy MR 1996 Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 16:694-703
52. Vo N, Goodman RM 2001 CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276:13505-13508
53. 2+-dependent prodynorphin transcriptional derepression in neuroblastoma cells is exerted through DREAM protein activity in a kinase-independent manner. Mol Cell Neurosci 22:135-145